Trial Profile
Clinical Trials Insight: 700013471
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2006
Price :
$35
*
At a glance
- Drugs LP 261 (Primary)
- Indications Cancer; Haematological malignancies; Solid tumours
- Focus Adverse reactions
- Sponsors Locus Pharmaceuticals
- 20 Jun 2006 New trial record.